Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Mueller

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Cell Biochemistry and Function|September 10, 2015
Dynamin function is important for chemokine receptor-induced cell migrationRichard O Jacques, Shirley C Mills, Paula Cazzonatto Zerwes, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 9, 2016
Spatiotemporal PFQNM visualization of the effect of suicide dendriplexes on dividing HeLa cellsHosam G Abdelhady, Hassan A Abdel-Salam, Esmaeel M Niazy, et al.
Oncoimmunology|September 14, 2020
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patientsMaria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptorAndrea Meiser, Anja Mueller, Emma L Wise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancerKousaku Mimura, Kensuke Shiraishi, Anja Mueller, et al.
Cellular and Molecular Life Sciences : CMLS|November 5, 2022
Induction of pulmonary HLA-G expression by SARS-CoV-2 infectionBarbara Seliger, Simon Jasinski-Bergner, Chiara Massa, et al.
Cancers|August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant MelanomaStefanie Meyer, Diana Handke, Anja Mueller, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapyMichael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.
Oncoimmunology|December 2, 2024
Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escapeMeron Yohannes, Chiara Massa, Zelalem Desalegn, et al.
Frontiers in Immunology|January 11, 2020
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome DisplayStina L Wickström, Tanja Lövgren, Michael Volkmar, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Cell Biochemistry and Function|September 10, 2015
Dynamin function is important for chemokine receptor-induced cell migrationRichard O Jacques, Shirley C Mills, Paula Cazzonatto Zerwes, et al.
Nanomedicine : Nanotechnology, Biology, and Medicine|July 9, 2016
Spatiotemporal PFQNM visualization of the effect of suicide dendriplexes on dividing HeLa cellsHosam G Abdelhady, Hassan A Abdel-Salam, Esmaeel M Niazy, et al.
Oncoimmunology|September 14, 2020
Identification of miR-200a-5p targeting the peptide transporter TAP1 and its association with the clinical outcome of melanoma patientsMaria-Filothei Lazaridou, Evamaria Gonschorek, Chiara Massa, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2008
The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptorAndrea Meiser, Anja Mueller, Emma L Wise, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 19, 2013
The MAPK pathway is a predominant regulator of HLA-A expression in esophageal and gastric cancerKousaku Mimura, Kensuke Shiraishi, Anja Mueller, et al.
Cellular and Molecular Life Sciences : CMLS|November 5, 2022
Induction of pulmonary HLA-G expression by SARS-CoV-2 infectionBarbara Seliger, Simon Jasinski-Bergner, Chiara Massa, et al.
Cancers|August 7, 2021
Distinct Molecular Mechanisms of Altered HLA Class II Expression in Malignant MelanomaStefanie Meyer, Diana Handke, Anja Mueller, et al.
Cancer Immunology, Immunotherapy : CII|August 4, 2019
Tumor-induced escape mechanisms and their association with resistance to checkpoint inhibitor therapyMichael Friedrich, Simon Jasinski-Bergner, Maria-Filothei Lazaridou, et al.
Oncoimmunology|December 2, 2024
Blood immune profiling of Ethiopian patients with breast cancer highlights different forms of immune escapeMeron Yohannes, Chiara Massa, Zelalem Desalegn, et al.
Frontiers in Immunology|January 11, 2020
Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome DisplayStina L Wickström, Tanja Lövgren, Michael Volkmar, et al.
Pageof 7